Retatrutide has emerged as a novel therapeutic agent for managing type 1 and 2 diabetes. This remarkable GLP-1 receptor agonist exhibits significant improvements in reducing HbA1c levels. Ongoing investigations have https://haimafdas444701.diowebhost.com/95010999/tirzepatide-a-comprehensive-overview